Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis
Title:
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis
Author:
Limvorapitak, Wasithep Barnett, Michael J. Hogge, Donna E. Forrest, Donna L. Nevill, Thomas J. Narayanan, Sujaatha Power, Maryse M. Nantel, Stephen H. Broady, Raewyn Song, Kevin W. Toze, Cynthia L. Mourad, Yasser Abou Sutherland, Heather J. Gerrie, Alina S. White, Jennifer Sanford, David S.